Predicting Colloidal Stability of High-Concentration Monoclonal Antibody Formulations in Common Pharmaceutical Buffers Using Improved Polyethylene Glycol Induced Protein Precipitation Assay.

MLA

Meza, Noemi P., et al. “Predicting Colloidal Stability of High-Concentration Monoclonal Antibody Formulations in Common Pharmaceutical Buffers Using Improved Polyethylene Glycol Induced Protein Precipitation Assay.” Molecular Pharmaceutics, vol. 20, no. 11, Nov. 2023, pp. 5842–55. EBSCOhost, https://doi.org/10.1021/acs.molpharmaceut.3c00694.

APA

Meza, N. P., Hardy, C. A., Morin, K. H., Huang, C., Raghava, S., Song, J., Zhang, J., & Wang, Y. (2023). Predicting Colloidal Stability of High-Concentration Monoclonal Antibody Formulations in Common Pharmaceutical Buffers Using Improved Polyethylene Glycol Induced Protein Precipitation Assay. Molecular Pharmaceutics, 20(11), 5842–5855. https://doi.org/10.1021/acs.molpharmaceut.3c00694

Chicago

Meza, Noemi P, Colin A Hardy, Kylie H Morin, Chengbin Huang, Smita Raghava, Jing Song, Jingtao Zhang, and Ying Wang. 2023. “Predicting Colloidal Stability of High-Concentration Monoclonal Antibody Formulations in Common Pharmaceutical Buffers Using Improved Polyethylene Glycol Induced Protein Precipitation Assay.” Molecular Pharmaceutics 20 (11): 5842–55. doi:10.1021/acs.molpharmaceut.3c00694.